SG3 Management, LLC - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 151 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$868,000
-7.3%
33,700
-10.1%
0.02%
+4.3%
Q1 2021$936,000
+96.2%
37,500
+114.3%
0.02%
+155.6%
Q4 2020$477,00017,5000.01%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,370,000$113,203,2005.24%
Finepoint Capital LP 761,721$11,700,0354.05%
Kynam Capital Management, LP 1,454,730$22,344,6533.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 441,019$6,769,6422.06%
MPM BioImpact LLC 552,846$8,491,7151.71%
ARMISTICE CAPITAL, LLC 7,450,000$114,432,0001.66%
SECTORAL ASSET MANAGEMENT INC 435,313$6,686,4081.12%
Octagon Capital Advisors LP 495,000$7,603,2001.06%
Orbimed Advisors 2,118,100$32,534,0160.59%
Rock Springs Capital Management LP 1,527,720$23,465,7790.56%
View complete list of TRAVERE THERAPEUTICS INC shareholders